Vidyasagar S. Glucose stimulates calcium-activated chloride secretion in small intestinal cells.
observation that cyclic adenosine monophosphate (cAMP) does not inhibit glucose-stimulated sodium absorption provided the physiological basis for oral rehydration solution (ORS) (1) . The introduction of glucose-based ORS in the 1970s provided a significant breakthrough in the treatment of cholera and other acute diarrheal conditions and saved the lives of millions of children and adults.
Despite substantial enhancement of glucose-stimulated fluid absorption and correction of dehydration and metabolic acidosis, ORS does not dramatically decrease stool output, which is one of the reasons for the underutilization of ORS (14) . Although an adequate explanation for this dichotomy has not been established, it could be explained if glucose also stimulated anion secretion. Efforts to modify and improve ORS to decrease stool output have been only modestly successful (29, (31) (32) (33) 37) . We initiated a series of experiments that systematically examined the effect of glucose on both sodium and chloride movement across the mouse small intestine and in human colorectal adenocarcinoma (Caco-2) cells. We found that glucose not only enhanced sodium absorption via SGLT1, a well-established phenomenon, but also stimulated active chloride secretion via an increase in intracellular Ca 2ϩ . These observations permit the speculation that in those clinical conditions in which there is villous atrophy and impaired glucosestimulated sodium absorption, glucose may have deleterious effects on overall fluid and electrolyte movement by virtue of its stimulation of active chloride secretion.
MATERIALS AND METHODS
Animal preparation. Eight-week-old, male, NIH Swiss mice were fed a normal diet and housed at four mice per cage. Following CO 2 inhalation, mice were humanely euthanized by cervical dislocation. Following exsanguination, the ileal mucosa was obtained as previously described (54, 55) . All experiments were approved by the University of Florida Institutional Animal Care and Use Committee. This study also received Insitutional Review Board approval (IRB201200129 and IRB201200058).
Bioelectric measurements and flux studies. Stripped ileal sheets were mounted between two halves of an Ussing chamber with 0.3 cm 2 of exposed surface area (P2304; Physiologic Instruments, San Diego, CA). The Ringer solution contained the following (mmol/l): 140 Na ϩ , 119. 8 Ϫ ; was bubbled with 95% O2 and 5% CO2 bilaterally; and was maintained at 37°C. After the tissues were allowed to stabilize for 45 min, the basal short-circuit current (I sc; expressed as eq·h Ϫ1 ·cm Ϫ2 ) and conductance (G; expressed as mS/cm 2 ), were recorded using a computer-controlled voltage/current clamp device (VCC MC-8; Physiologic Instruments) as previously described (54, 55) . To determine if an apical membrane sodium channel contributed to the basal I sc, amiloride (10 M) was added to the lumen side. The addition of amiloride (10 M) did not significantly decrease the Isc (1.6 Ϯ 0.1 vs. 1.4 Ϯ 0.1 eq·h Ϫ1 ·cm Ϫ2 ; n ϭ 15), confirming the absence of amiloride-sensitive electrogenic sodium absorption in the ileum. The basal I sc was, therefore, primarily attributed to electrogenic chloride and/or HCO 3 Ϫ secretion via a chloride channel. Epithelial sodium channels were similarly excluded in tissues stimulated with glucose. Amiloride did not inhibit the glucose-stimulated increase in the I sc (8.0 Ϯ 0.5 vs. 7.8 Ϯ 0.6 eq·h Ϫ1 ·cm Ϫ2 ; n ϭ 15; P ϭ NS), ruling out the role for epithelial sodium channels. Anion channel activity in the presence of glucose was studied by adding 100 M of 5-nitro-2-(3-phenylpropylamino) benzoate (NPPB), a nonspecific anion channel blocker, to the lumen side. Glibenclamide was used as a cystic fibrosis transmembrane conductance regulator (CFTR) channel blocker, although we are aware that the inhibitor also blocks potassium channels and that its inhibitory effects are not specific to CFTR. In these present experiments and in our previous publications (2, 3, 5), we had results with glibenclamide that were comparable to those achieved with CFTR(inh)-172. We also observed that the inhibition of the I sc achieved with glibenclamide was relatively rapid compared with that achieved with CFTR(inh)-172; however, the degree of inhibition of these two inhibitors was identical. This rapidity of inhibition was felt to be critical during 36 Cl flux studies. In forskolinstimulated tissues, glibenclamide (7.5 Ϯ 0.5 vs. 0.6 Ϯ 0.2 eq·h Ϫ1 ·cm Ϫ2 ; P Ͻ 0.001) and CFTR(inh)-172 (7.3 Ϯ 0.7 vs. 1.8 Ϯ 0.2 eq·h Ϫ1 ·cm Ϫ2 ; P Ͻ 0.001) resulted in similar levels of inhibition. For flux studies, radioisotopes of sodium ( 22 Na) and chloride ( 36 Cl) were used to study sodium and chloride fluxes across the ileal mucosa in the presence and absence of glucose as previously described (47, 55) . 22 Na activity was measured using a gamma counter (Wizard 2, 2480 Automatic Gamma Counter; Perkin Elmer), while 36 Cl was measured using a liquid scintillation counter (LS 6500 Multipurpose Scintillation Counter; Beckman Coulter, Brea, CA). The presence of basal electroneutral Na-H exchange activity was determined by using 10 M of 5-(N,N-hexamethylene) amiloride (HMA), a selective inhibitor of NHE3 (27) . Basal Cl-HCO 3 exchange activity was inhibited by 100 M of 4=-diisothiocyano-2,2=-stilbenedisulfonic acid (DIDS), an anion exchange inhibitor (9, 19, 20) . Glibenclamide (100 M), a relatively specific CFTR channel blocker, was added to the lumen side after glucose to study the presence of a CFTR channel activity. In separate experiments, niflumic acid (10 M), a calciumactivated chloride channel blocker, was added to the lumen side to determine the presence of calcium-activated chloride channel activity in the presence of glucose (23, 46, 48) .
Glucose or 3-O-methylglucose-stimulated saturable kinetics. Saturation kinetics were studied after increasing concentrations of glucose (up to 8 mM) were added to the lumen side in the presence of 140 mM of sodium, and changes in the I sc were recorded. Tissues were allowed to equilibrate for 10 min after each addition. The peak current for each glucose concentration was used for fitting the data. The nonlinear curve fit with the Michaelis-Menten model for enzyme kinetics was used to calculate the K m and Vmax. Phlorizin (50 M; Santa Cruz Biotechnology, Santa Cruz, CA), a reversible competitive inhibitor of SGLT1 (11, 25, 49) , was used to determine whether glucose transport via SGLT1 is essential for the glucose-stimulated increase in the I sc. It was first added to the lumen side before increasing concentrations of glucose were added.
To determine whether a metabolizable form of glucose is essential for the glucose-stimulated increase in the Isc, saturation kinetic studies were repeated in the presence of 3-O-methylglucose (3-OMG), a nonmetabolizable form of glucose (10, 28) . These studies were similar to those for glucose.
Ileal sacs for immunohistochemistry and brush border membrane vesicle preparation. Ileal segments were tied at one end and filled with 200 l of 1) Ringer or 2) glucose-containing Ringer solution. The sac was then placed in a beaker containing O 2-saturated Ringer solution at 37°C. The beaker containing the oxygenated Ringer solution with the sac was slowly agitated in a water bath at 37 o C and continuously bubbled with 95% O 2-5% CO2. After incubating for 60 min, the sacs were removed from the beaker and the tissues either rapidly fixed for immunohistochemistry or the mucosa was scraped for brush border membrane vesicle (BBMV) preparation. BBMV were prepared using a modified methods from Stieger et al. (44) and Binder et al. (3) and stored in a buffer containing a protease inhibitor mixture (10 mM of iodoacetamide, 1 mM of phenylmethylsulphonyl fluoride and 2 g/ml of leupeptin) with a pH of 7.4. Protein concentrations were determined in samples using the Bradford assay.
Caco-2 cell culture. To determine whether a glucose-stimulated increase in the I sc was also present in other tissues, we performed parallel studies in Caco-2 cells (American Type Culture Collection, Manassas, VA) (4, 7, 15, 30) . Caco-2 cells were cultured in Eagle's minimal essential medium supplemented with 10% fetal bovine serum and 1% nonessential amino acids at 37°C and 5% CO 2. Cells were passaged 20 -25 times, seeded (2 ϫ 10 5 cells/dish) in 5-cm Petri dishes, and grown to 80% confluence; thereafter, the fetal bovine serum concentration was changed to 5%. Cells were grown for another 10 days before they were used for functional studies. Immunohistochemisty and Western blot analysis were performed to determine the presence of SGLT1 and a calcium-activated chloride channel. Inhibitors were added to the apical side of the permeable insert.
Colorimetric cAMP measurements. Freshly isolated ileal epithelial cells obtained by mucosal scrapping and subsequently washed three times in a Ringer solution containing 1.2 mM of Ca 2ϩ at 37°C were used to measure intracellular cAMP. Washed cells were then divided into two groups and treated with either saline or 6 mM of glucose and incubated for 45 min. The cell lysates were then used for a cAMP direct immunoassay (Calbiochem, EMD Millipore, Billerica, MA). cAMP levels were measured, as described in a previous publication (55) (expressed in pmol/mg protein). Forskolin-treated cells were used as a positive control. Glucose-treated and forskolin-treated cells were incubated for 45 min. All assays were performed in triplicate and repeated on ileal cells from four different mice to obtain n ϭ 4.
Confocal Ca 2ϩ fluorescence microscopy. Caco-2 cells grown in a 25-mm, round coverslip were mounted on a RC-21BR bath chamber attached to a Series 20 stage adapter (Warner Instruments, Hamden, CT). A single-channel tabletop temperature controller (TC-324B; Warner Instruments) maintained cells at 37°C. Cells were loaded with 0.5 M of the fluorescent calcium indicator Fluo-8 AM dye (cat no. 0203; TEF Laboratory, Austin, TX) and incubated for 45 min at room temperature. Confocal laser scanning microscopy was performed using an inverted Fluoview 1000 IX81 microscope (Olympus, Tokyo, Japan) and a U Plan S-Apo ϫ20 objective. Fluorescent images were captured with a scanning confocal microscope fitted with argon lasers with an excitation of 488 nm and emission of 515 nm wavelengths. Solutions of Ringer, glucose-containing Ringer, or BAPTA-AMcontaining glucose-Ringer were added to the bath chamber using a multivalve perfusion system (VC-8; Warner Instruments). Cells were washed with Ringer solution, and the experiment was repeated with 3-OMG and carbachol.
Immunohistochemistry. Immunohistochemistry was performed using methods described previously (54, 55) . Ileal tissues were collected from ileal sacs incubated with Ringer or Ringer containing 8 mM of glucose and were fixed in formalin (10%) for 20 h at room temperature and then embedded in paraffin. Tissue sections (4 m) were obtained using microtome (Leica RM2245; Leica Microsystems, Buffalo Grove, IL) and then fixed onto glass slides. Primary antibody [SGLT-1 and anoctamin 1 (ANO1)] diluted in TBS (1:500) containing 1% BSA was incubated overnight at 4°C. Thereafter, the slides were incubated with fluorophore-conjugated secondary antibody (Alexa Fluor 647 goat anti-rabbit IgG, A-21245; Life Technologies, Carlsbad, CA) at 1:1,000 dilution in TBS. The slides were then imaged under the confocal laser scanning microscopy (Fluoview 1000 IX81 microscope; Olympus, Tokyo, Japan) using a 633-nm laser.
Western blot analysis. Western blot was performed using BBMV prepared from intestinal sacs incubated with Ringer or with glucoseRinger solutions. Thirty micrograms of mouse ileal protein obtained from tissues incubated with glucose or saline were resolved by electrophoresis through SDS-7.5% polyacrylamide gels, as described by Ranganathan et. al (36) . Blots were subsequently reacted with rabbit anti-ANO1 antibody (Aviva Systems Biology, San Diego, CA) at a 1:500-to 1,000-fold dilution, followed by peroxidase-coupled secondary antibody at a 1:3,000-fold dilution. Immunoreactive bands were visualized by enhanced chemiluminescence (Pierce ECL Western blotting substrate; Thermo Scientific) and autoradiography. Blots were stained with Ponceau S solution to confirm comparable sample loading and transfer.
Statistics. Results are presented as means Ϯ SE. Statistical analyses were performed with paired and unpaired t-tests and Bonferroni's one-way analysis of variance post hoc test. P Ͻ 0.05 was considered significant.
RESULTS
Effects of glucose on the I sc and unidirectional and net fluxes of Na. Ileal tissues mounted in the Ussing chamber exhibited a basal I sc of 1.7 Ϯ 0.1 eq·h Ϫ1 ·cm Ϫ2 . Glucose (8 mM) added to the lumen side of ileal tissues led to a significant increase in the
Ϫ2 ) was abolished in the presence of HMA (27) 
; n ϭ 15; P Ͻ 0.001), thereby confirming that basal sodium absorption represented Na-H exchange. Glucose (8 mM) added to the lumen side of the tissues resulted in a significant increase in net sodium flux (J net Na; 5.0 Ϯ 0.5 eq·h Ϫ1 ·cm Ϫ2 ; Fig. 1B ) and was due to a significant increase in mucosal-to-serosal flux (J ms ; Table 1 ). HMA was added to the lumen side and resulted in significant inhibition (3.2 Ϯ 0.3 eq·h Ϫ1 ·cm Ϫ2 ), indicating an NHE3-mediated net flux of 1.8 eq·h Ϫ1 ·cm Ϫ2 comparable to that identified in the absence of glucose (1.5 eq·h Ϫ1 ·cm Ϫ2 ). Thus the HMA-insensitive portion of the J net Na represents glucose-stimulated sodium absorption.
The glucose-stimulated increase in J net Na of 3.4 eq·h Ϫ1 ·cm Ϫ2 over basal J Net Na (5.0 Ϯ 0.5 -1.6 Ϯ 0.3 eq·h Ϫ1 ·cm Ϫ2 ) was significantly less than the change in the glucose-stimulated I sc [6 Fig. 1, A and B] and raised the possibility that glucose also stimulated chloride secretion. In addition, the change in J net Na (3.2 Ϯ 0.3 eq·h Ϫ1 ·cm
Ϫ2
) in the presence of HMA in tissues exposed to glucose was considerably less than the glucose-induced increase in the I sc (6.3 eq·h Ϫ1 ·cm Ϫ2 ). Effect of chloride channel blockers on the glucose-stimulated increase in the I sc . The addition of NPPB to tissues with a glucose-stimulated increase in the I sc resulted in a significant decrease in the I sc , suggesting anion channel activity (8.0 Ϯ 0.5 vs. 2.6 Ϯ 0.1 eq·h Ϫ1 ·cm Ϫ2 ; n ϭ 15; P Ͻ 0.001). Glibenclamide did not affect the glucose-stimulated I sc , but 10 M of niflumic acid added to the lumen side resulted in significant inhibition of the glucose-stimulated increase in I sc (Fig. 1C) . The calcium-activated chloride channel blocker CaCC(inh)-A01 was used in limited studies to inhibit the glucose-stimulated increase in the I sc (6.2 Ϯ 0.4 vs. 2.8 Ϯ 0.5 eq·h Ϫ1 ·cm Ϫ2 ; P Ͻ 0.001); the results were similar to those achieved with niflumic acid (Fig. 1C) . Since there was not a substantial difference in the degree of inhibition of the glucose-stimulated current in the presence of niflumic acid or CaCC(inh)-A01, we 22 Na flux studies showed net sodium absorption in the basal state. Glucose led to a significant increase in net sodium flux. C: glibenclamide (100 M) had no effect on the glucose-stimulated Isc, whereas niflumic acid (10 M) led to a significant decrease in Isc. D: 36 Cl flux studies showed net chloride absorption in the basal state. Glucose resulted in significant chloride secretion. Niflumic acid (NFA) but not glibenclamide inhibited glucose-stimulated chloride secretion. The numbers shown in parenthesis represent n number of tissues, each dot represents a data point from a tissue, and the horizontal bars indicate the means Ϯ SE.
continued to use niflumic acid. These studies suggest the possibility that a niflumic-sensitive chloride channel was linked to an increase in the I sc (Fig. 1C) .
Effects of glucose on unidirectional and net fluxes of Na and Cl. J net Cl determined in the absence of glucose demonstrated net absorption (1.6 Ϯ 0.2 eq·h Ϫ1 ·cm Ϫ2 ) that was inhibited by DIDS (9, 19, 20) , (0.3 Ϯ 0.1 eq·h Ϫ1 ·cm
; P Ͻ 0.001) and HMA (1.6 Ϯ 0.2 vs. 0.2 Ϯ 0.1 eq·h Ϫ1 ·cm Ϫ2 ). These results confirm that basal chloride absorption likely represents a chloride-anion exchange. Since basal J net Na (1.6 Ϯ 0.3 eq·h Ϫ1 ·cm Ϫ2 ) was equal to that of chloride absorption (1.6 Ϯ 0.2 eq·h Ϫ1 ·cm
; P ϭ NS) and inhibition of Na-H exchange by HMA resulted in inhibition of Cl absorption, basal sodium and chloride absorption likely represented parallel and coupled Na-H and Cl-HCO 3 exchanges. Glucose (8 mM) added to the mucosal side stimulated net chloride secretion (Ϫ3.4 Ϯ 0.4 eq·h Ϫ1 ·cm Ϫ2 ) (Fig. 1D ) and was a result of a significant increase in serosal-to-mucosal flux of chloride (J sm Cl) (11.7 Ϯ 0.4 vs. 16.4 Ϯ 0.4 eq·h Ϫ1 ·cm Ϫ2 ; Table 1 ). These studies indicate that glucose stimulates a significant rate of chloride secretion.
Mucosal addition of glibenclamide (100 M) had no effect on unidirectional or net fluxes of chloride in the presence of glucose (Table 1 and Fig. 1D) (38, 42, 43) . However, J sm Cl and J net Cl were significantly inhibited by niflumic acid (10 M) ( Table 1 ). These studies indicate that glucose stimulates anion secretion via a niflumic acid-sensitive apical membrane chloride channel.
Effects of BAPTA-AM on glucose-stimulated increase in the I sc . BAPTA-AM (50 M) was added as a cell permeant Ca 2ϩ chelater to the lumen side under basal conditions and then exposed to 8 mM of glucose to determine if intracellular calcium was essential for the glucose-stimulated increase in the I sc . The addition of glucose resulted in a significant increase in the I sc , which was significantly lower compared with glucose stimulation in the absence of BAPTA-AM (Figs. 1A and 2A ). Further addition of 10 M of niflumic acid did not have a significant effect on the I sc . These studies suggest that glucose activation of the niflumic acid-sensitive chloride channel is associated with an increase in intracellular calcium.
Effects of bumetanide on glucose-stimulated increase in the I sc . Movement of chloride across the apical membrane in the presence of glucose requires chloride entry at the basolateral side. Sodium-potassium-2 chloride cotransporter 1 (NKCC1) is known to transport chloride across the basolateral membrane into the cell and is blocked by serosal addition of a potent NKCC1 inhibitor, 100 M of bumetanide. Bumetanide was added both before and after stimulation with glucose. Tissues preincubated with bumetanide showed a small but significant increase in the I sc following the addition of glucose (Fig. 2B ). Subsequent addition of niflumic acid (10 M) to the lumen side did not result in a significant change in the I sc (Fig. 2B) . Bumetanide added after glucose stimulation showed a significant decrease in the I sc , which was not further altered by niflumic acid (Fig. 2C) .
Effects Table 2 ). Effect of glucose on saturable kinetics of the I sc . The addition of increasing concentrations of glucose (up to 8 mM) to the lumen side revealed the saturation kinetics of the I sc (Fig. 3A) . The glucose studies demonstrated early signs of saturation at low concentrations (0 -0.6 mM); however, subsequent addition of glucose resulted in a further increase in the I sc that saturated at high concentrations of glucose (0.6 -8 mM). Because the I sc response suggested the possible presence of more than one transporter with different Michaelis constant (K m ) values at low and high concentrations of glucose, the K m was calculated for low-and high-glucose concentrations. The K m was 0.7 Ϯ 0.2 mM at the low-glucose concentration and 1.9 Ϯ 0.1 mM at the high concentration. The corresponding V max values were 2.5 Ϯ 0.5 and 5.0 Ϯ 0.7 eq·h Ϫ1 ·cm Ϫ2 , respectively. The significant difference (n ϭ 9; P Ͻ 0.001) between the K m values suggests that more than one transporter may account for the glucose-stimulated increase in the I sc . Values are means Ϯ SE. Numbers in parentheses represent number of tissues per group. Jms, mucosal to serosal flux; Jsm, serosal to mucosal flux; Jnet, net flux of Na or Cl; G, conductance; Isc, short-circuit current; NFA, niflumic acid; NS, not specified. *Glucose-treated tissues were compared to basal tissues.
†Tissues treated with inhibitors were compared with tissues treated with glucose.
Effect of phlorizin on glucose-stimulated increase in I sc . The I sc was completely inhibited by the mucosal addition of phlorizin (8.0 Ϯ 0.5 vs. 0.2 Ϯ 0.1 eq·h Ϫ1 ·cm Ϫ2 ; n ϭ 15; P Ͻ 0.001). Saturation kinetics in the presence of phlorizin showed that the increase in the I sc was abolished at all glucose concentrations, suggesting that a functional SGLT1 is essential both for glucose-stimulated sodium absorption and for chloride secretion (Fig. 3A) .
Effect of 3-OMG on the I sc and 36 Cl flux. Increasing concentrations of 3-OMG added to the lumen side revealed saturation kinetics with a V max of 2.3 Ϯ 0.1 eq·h Ϫ1 ·cm Ϫ2 and a K m of 0.2 Ϯ 0.1 mM (Fig. 3A) . 36 Cl flux studies in the presence of 3-OMG did not show a significant difference from that of the basal J net Cl (1.6 Ϯ 0.2 vs. 1.7 Ϯ 0.2 eq·h Ϫ1 ·cm Ϫ2 ), whereas 22 Na flux studies showed a significant increase in J Net Na (1.6 Ϯ 0.3 vs. 2.9 Ϯ 0.3 eq·h Ϫ1 ·cm
). These results indicate that 3-OMG stimulates active Na absorption but not active Cl secretion.
Effect of serosal addition of glucose on the I sc . To confirm that the apical addition of glucose stimulated an increase in the I sc , glucose was added to the bath (serosal) side. The bath addition of 8 mM of glucose did not stimulate an increase in the I sc .
Effect of low concentrations of glucose on unidirectional net flux of sodium and chloride. 22 Na and 36 Cl flux studies performed at a low glucose concentration (0.6 mM) revealed a small but significant increase in the J net Na and a larger increase in net chloride secretion (Fig. 3, B and C) . Net chloride secretion in the presence of glucose was due to an increase in the unidirectional serosal to mucosal flux of chloride.
Effect of glucose on the I sc in Caco-2 cells. To determine if a similar glucose-stimulated increase in the I sc was seen in human epithelial cells with intestinal differentiation, studies were performed on Caco-2 cells that were grown on permeable inserts. Caco-2 cells exposed to glucose exhibited a significant increase in the I sc (Fig. 3D) . The addition of niflumic acid resulted in a significant decrease in the glucose-stimulated increase in the I sc (Fig. 3D) , thereby suggesting the activation of a calcium-activated anion channel. Glibenclamide had no effect on the glucose-stimulated increase in the I sc .
Effect of glucose on intracellular cAMP. Cell lysates incubated with glucose (0.6 or 6 mM) or with 3-OMG (0.6 or 6 mM) did not induce a significant increase in intracellular cAMP, compared with the cell fractions not treated with either 3-OMG or glucose (Fig. 4A) . A positive control with forskolin confirmed an increase in intracellular cAMP. Consequently, the results do not support a role for intracellular cAMP con- A: incubation of tissues with BAPTA-AM (50 M) for 45 min had no effect on the basal Isc. Glucose (8 mM) added to the lumen side resulted in a significant increase in the Isc. Niflumic acid (10 M) added to the lumen side did not change the glucosestimulated increase in the Isc. B: incubation of tissues with bumetanide for 45 min had no effect on the basal Isc. Glucose (8 mM) added to the lumen side resulted in a significant increase in the Isc. Niflumic acid (10 M) added to the lumen side had no effect on the glucose-stimulated increase in Isc (8 mM). C: bumetanide (100 M) was added after glucose. Bumetanide resulted in a significant decrease in the Isc that was not further inhibited by niflumic acid. D: 36 Cl flux studies in tissues incubated with bumetanide or BAPTA-AM for 45 min in Ussing chamber. The addition of glucose or subsequent additions of niflumic acid had no significant effect on JNetCl. The values are from n ϭ 8 pairs of tissues, each dot represents a data point from a tissue, and the horizontal bars indicate the means Ϯ SE. ] i ). Postconfluent Caco-2 cells were used for subsequent [Ca 2ϩ ] i measurements as the mouse ileal cells did not adhere to the coverslips for extended periods, and stable recordings were not possible. Glucose (0.6 mM) added to the bathing medium initiated intracellular Ca 2ϩ oscillations (Fig. 4D) . The amplitude of each oscillation was sustained for at least 200 s (Fig. 4B) . The mean peak amplitude of F/Fo was calculated as 1.32 Ϯ 0.1 (n ϭ 10). To determine if the increase in intracellular Ca 2ϩ was due to glucose metabolism, 3-OMG (10, 28) was also used (Fig. 4C) . 3-OMG (0.6 mM) did not induce a similar increase in Ca 2ϩ oscillations (1.0 Ϯ 0.1; n ϭ 10) and suggested that the increase in intracellular Ca 2ϩ required a metabolizable form of glucose. Preincubating the cells with 50 M of BAPTA-AM, an intracellular calcium chelater, for 45 min abolished glucose-stimulated Ca 2ϩ oscillations (1 .0 Ϯ 0.1; n ϭ 10; Fig. 4C ). These results confirm that glucose is associated with an increase in intracellular Ca 2ϩ . A higher glucose concentration (6 mM) also increased the amplitude of Ca 2ϩ oscillations (1.85 Ϯ 0.20 vs. 1.32 Ϯ 0.10) (Fig. 4D) . 3-OMG (6 mM) added to the bathing medium failed to elicit an increased [Ca 2ϩ ] i response at concentrations of 0.6 mM or 6 mM (1.0 Ϯ 0.1 vs. 1.0 Ϯ 0.2; Fig. 4C) .
Immunostaining for SGLT1 and ANO1 expression in mouse small intestines. Immunostaining using a mouse-specific SGLT1 antibody demonstrated maximal staining on the villi tips, along the brush border membrane (Fig. 5, A and B) and minimal expression on crypt cells in tissues from ileal sacs incubated with 8 mM of glucose. Immunostaining using a mouse-specific antibody for ANO1, a calcium-activated chloride channel expressed on the apical membrane of small intestinal epithelial cells (6, 16, 53) , revealed expression in the upper one third of the villous and lower one third of the crypt cell regions (Fig. 5, C and D) . However, immunohistochemistry from tissues incubated with glucose (8 mM) demonstrated increased ANO1 expression along the upper villous, midvillous, and low-villous regions and along the brush border membrane (Fig. 5, E and F) . Minimal expression was seen in the crypt cell region (Fig. 5, E and F) .
Western blot analysis for ANO1 in mouse ileum. Tissue samples incubated with glucose showed increased ANO1 protein levels at 80 kDa, compared with Ringer controls (Fig. 5G) . These results are consistent with immunohistochemistry and isotopic flux data that suggest glucose-activation of a calciumdependent chloride channel.
DISCUSSION
Stimulation of active electrogenic sodium absorption by glucose via SGLT1 in the mammalian small intestine is a well-established physiological process that has been extensively studied over the past 40 years (8, 17, 50 -52) . Although glucose enhances intestinal sodium and water absorption, which is the physiological basis for the development of ORS in the treatment of acute diarrhea, ORS is not associated with a dramatic reduction in diarrhea (i.e., stool output) (14) . Our results demonstrated that the glucose-stimulated increase in the I sc was considerably greater than the enhancement of active sodium absorption, as measured by 22 Na fluxes. The J net Na is the sum of electrogenic (sodium-coupled glucose transport) and electroneutral (Na-H exchange) sodium absorption. NHE3 exchange is the predominant Na-H exchange in the basal state and in the presence of glucose (18, 24, 26, 56) . Mucosal HMA in the presence or absence of glucose resulted in comparable inhibition of NHE3-dependent sodium absorption (5.0 Ϯ 0.5 -3.2 Ϯ 0.3 eq·h Ϫ1 ·cm Ϫ2 and 1.6 Ϯ 0.3 vs. 0.1 Ϯ 0.1 eq·h Ϫ1 ·cm Ϫ2 ), respectively. Thus HMA-insensitive sodium flux (3.2 Ϯ 0.3 eq·h Ϫ1 ·cm Ϫ2 ) reflects SGLT1-mediated electrogenic sodium absorption. In contrast, glucose also stimulates active chloride secretion such that the increases in electrogenic chloride secretion and electrogenic sodium absorption are equivalent to its increase in the I sc . The J net Cl is the sum of electrogenic chloride secretion and electroneutral the Cl-HCO 3 Ϫ exchange-mediated chloride absorption. Net chloride secretion did not result in a significant change in J ms Cl (Table  1) , thereby suggesting that Cl-HCO 3 Ϫ exchange persists in the presence of glucose. Thus the net change in chloride flux was equal to basal chloride absorption (1.6 Ϯ 0.2 eq·h Ϫ1 ·cm Ϫ2 ) plus the net chloride secretion in the presence of glucose (Ϫ3.5 Ϯ 0.4 eq·h Ϫ1 ·cm Ϫ2 or 5.1 eq·h Ϫ1 ·cm Ϫ2 ). These results established that the glucose-stimulated increase in the I sc (8.0 Ϯ 0.5 eq·h Ϫ1 ·cm Ϫ2 ) was equal to the sum of electrogenic chloride secretion (5.1 eq·h Ϫ1 ·cm Ϫ2 ) and electrogenic sodium absorption (3.2 Ϯ 0.3 eq·h Ϫ1 ·cm Ϫ2 ). The present studies provide compelling evidence that glucose stimulates active chloride secretion, which is mediated by an increase in intracellular calcium. First, the glucose-stimulated I sc was inhibited by NPPB, a nonspecific anion channel inhibitor. Second, niflumic acid, a calcium-activated chloride channel blocker, but not glibenclamide, a CFTR channel inhibitor, prevented glucose-stimulated chloride secretion. Third, glucose increased intracellular calcium but not intracellular cAMP levels. Fourth, in tissues incubated with BAPTA-AM or bumetanide, the glucose-stimulated increase in the I sc was approximately equal to J Net Na. BAPTA-AM chelated the increase in intracellular calcium secondary to glucose stimulation, resulting in the subsequent failure to observe calciumactivated chloride secretion ( Fig. 2A) . Bumetanide inhibited the NKCC1-mediated chloride entry into the cell at the basolateral side, which is essential for its apical exit and prevents a chloride secretory response to luminal glucose (Fig. 2D) . Thus, by preventing the glucose-stimulated increase in intracellular calcium or by preventing the chloride entry into the cell at the basolateral side, we demonstrated that the observed glucoseinduced increase in the I sc is not completely accounted for by J Net Na and represents chloride secretion, which requires an increase in intracellular calcium for its activation. Finally, glucose induced ANO1 protein expression on the brush border membrane, a potential calcium channel protein. The molecular identity of the calcium-activated chloride channels was largely unknown until the recent identification of anoctamins 1 through 10 (6, 16, 53) . Of these anoctamins, ANO1 is broadly expressed in mammalian tissues, including the gastrointestinal tract (35) . Like ANO1, mCLCA6 is another calcium-activated chloride channel that is expressed in mouse small intestines (12) . mCLCA6 is an integral apical membrane protein and colocalizes with CFTR (5). However, further studies will be essential to determine whether the chloride secretory response occurs via ANO1 and /or mCLCA6. A metabolizable hexose that is transported across the apical membrane is required for stimulation of active Cl secretion in the mouse ileum as neither glucose in the presence of phlorizin, an inhibitor of glucose uptake across the apical membrane; 3-OMG, a glucose metabolite that is transported via SGLT1 across the apical membrane but not metabolized; nor glucose added to the serosal bathing solution stimulated active Cl secretion (Fig. 3A) . These present observations are not the initial demonstration that glucose enhances Cl secretion in the mammalian small intestine (2, 34, 41, 45) . The initial detailed studies that demonstrated glucose stimulation of Na absorption were performed in the rabbit ileum (39 -41) . These studies by Schultz and Zalusky (40) and Schultz et al. (41) did not provide any suggestion that glucose modified Cl transport. Other studies that were performed in the 1970s in both hamster and rat small intestines provided evidence that glucose might stimulate active Cl secretion but did not reveal a consistent pattern (2, 34, 41, 45) . For example, in the hamster ileum, active Na-Cl secretion was demonstrated in the absence of glucose, and the addition of glucose stimulated active Na-Cl secretion (2) . Similar to our present observations, neither 3-OMG nor serosal glucose stimulated Cl secretion (2) . Studies in rat small intestines also have indicated that glucose may stimulate Cl secretion, in addition to its well-established enhancement of Na absorption (41, 45) . None of these older studies examined a link between glucose and Cl secretion (e.g., second messengers or the mechanism by which glucose might stimulate active Cl secretion). However, the well-established phenomenon in pancreatic islet cells that glucose increases insulin release via an increase in intracellular calcium may be of relevance to our present observations (13, 21) .
While we found that active sodium absorption was higher at 8 mM of glucose compared with 0.6 mM (Figs. 1, A and B and   3B ), active chloride secretion was similar in magnitude at these two glucose concentrations ( Fig. 1D and 3C ). Since SGLT1 and ANO1 are predominantly located along the brush border membrane of the villi (Fig. 5, A-F) , we suspect that in clinical or experimental conditions glucose-stimulated chloride secretion mostly occurs in the villous cell region. Further studies are, however, essential to determine the role of the crypt in the glucose-stimulated increase in chloride secretion. Indeed, studies show that rehydration with ORS is generally less successful for rotavirus-induced diarrhea, which is associated with the calcium-dependent enterotoxin NSP4 and modest changes in villous morphology, than for cholera-induced diarrhea, which is not associated with any histological abnormalities (22) . We speculate that simple dietary modifications and/or changes in the ORS formulation, such that glucose is replaced with compounds that do not stimulate chloride secretion, could significantly alter the outcome of the disease process.
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